ABOUT ROOSTERBIO

RoosterBio accelerates human mesenchymal stem/stromal cell (hMSC) and extracellular vesicle (EV) product and process development to fuel the rapid commercialization of scalable regenerative cures. Our high-quality hMSCs, bioprocess media, genetic engineering tools, and EV production solutions are paired with expert bioprocessing knowledge to progress therapeutic developers from concept to first-in-human testing and commercial manufacturing at reduced cost and increased productivity. With optimized, scalable processes, Type 2 Drug Master Files, and cGMP products, we have enabled therapeutic programs to traverse their path to clinical translation in under 1 year.

RoosterBio is driven by our client's success and creating a world where safe and effective regenerative medicines are rapidly developed and widely available on a global scale.

FEATURED ARTICLES

CONTACT INFORMATION

RoosterBio

5295 Westview Drive Suite 275

Frederick, MD 21703

UNITED STATES

Phone: 240-831-4914

RESOURCES

  • When MSCs are genome-edited, it will inevitably be done with cell therapy in mind and should involve complementary breakthroughs to scale up and industrialize gene delivery.